Drug Detail

Information about Cobimetinib + MPDL3280A

Generic Name	Cobimetinib + MPDL3280A
IND
Brand Name (US)
Manufacturer	Hoffman-La Roche
Drug Type
Delivery	Oral + Intravenous
Approval Status
Indications
Overall Strategy	tumor signal path + immune system
Strategy	Block related tumor path + stimulate immune system
Drug Category	MEK inhibitor + PD-L1 inhibitor

Links
Trials of this drug
	A Phase 1b Study of MPDL3280A (an Engineered Anti-PDL1 Antibody) in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic Solid Tumors

Trial results